Do Not Rush to Omit Sentinel Lymph Node Biopsy for Early Breast Cancer Patients
Clinical Breast Cancer · 2026
DOI: 10.1016/j.clbc.2025.11.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Níamh M Smyth und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, RCSI: University of Medicine and Health Sciences, Dublin, Ireland; Department of Surgery, Connolly Hospital, Blanchardstown, I…. Hauptthemen laut MEDLINE: Breast Neoplasms, Sentinel Lymph Node Biopsy, Carcinoma, Ductal, Breast. Die Arbeit nennt 36 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: Recent data suggest that sentinel lymph node biopsy (SLNB) can be omitted in select patients with early breast cancer. The aim of this study was to determine the utility of SLNB for patients with early breast cancer. METHODS: A retrospective analysis of patients diagnosed with breast cancer in a Level IV hospital in Dublin, Ireland, between December 2013 and March 2024 was conducted. Inclusion criteria included: female patients ≥ 18 years, with cT1 disease and a negative preoperative axillary ultrasound, who underwent breast conserving surgery and a SLNB. RESULTS: In total, 334 patients were included. The median age was 59 years (26-91 years). The majority had invasive ductal carcinoma (261 patients, 78.1%) and were hormone receptor-postive and human epidermal growth factor receptor 2-negative (274 patients, 82%). Final N stage was N0 in 282 (84%) of patients. Fifty-two patients (16%) had a positive-SLNB, despite a negative preoperative axilla. Twenty-four patients underwent an axillary clearance, of which 7 (14%) were positive, with only 3 patients (12.5%) upstaged following axillary clearance. Eighty-four patients (25%) received chemotherapy due to positive-SLNB. In line with contemporary data, 9 patients (2.7%) were eligible for CDK4/6 inhibitors, 48 patients (14%) for escalation to nodal radiation, or 275 patients (82%) for de-escalation to partial breast radiation. CONCLUSION: While SLNB may be safely omitted in specific contexts, its omission carries the risk of under- and over-treatment. Our findings demonstrate that SLNB continues to guide adjuvant therapy for breast cancer patients, and thus, support the ongoing use of SLNB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, RCSI: University of Medicine and Health Sciences, Dublin, Ireland; Department of Surgery, Connolly Hospital, Blanchardstown, Ireland. Electronic address: niamhmarysmyth@rcsi.com.
- Department of Surgery, RCSI: University of Medicine and Health Sciences, Dublin, Ireland; Department of Surgery, St Vincents Hospital, Elm Park, Ireland.
- Department of Surgery, Beaumont Hospital, Beaumont, Ireland.
- Department of Surgery, RCSI: University of Medicine and Health Sciences, Dublin, Ireland; Department of Surgery, Beaumont Hospital, Beaumont, Ireland.
- Department of Health Outcomes Research, Data Science Centre, RCSI, Dublin, Ireland.
- Clinical Data Science Centre, Beaumont Hospital, Beaumont, Ireland.
Zitieren
APA
Smyth, N. M., Zaborowski, A. M., Bolarinwa, B. V., Hembrecht, S., Culhane, R. J., Narsiman, A., Canavan, C. T., Sørensen, J., Downey, E., Allen, M., Butt, A., Power, C., McArdle, O., Morris, P. G., Healy, N., McKenna, L., & Hill, A. D. K. (2026). Do Not Rush to Omit Sentinel Lymph Node Biopsy for Early Breast Cancer Patients. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.11.006
Vancouver
Smyth NM, Zaborowski AM, Bolarinwa BV, Hembrecht S, Culhane RJ, Narsiman A, et al. Do Not Rush to Omit Sentinel Lymph Node Biopsy for Early Breast Cancer Patients. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.11.006
BibTeX
@article{Smyth2026,
author = {Smyth, Níamh M and Zaborowski, Alexandra M and Bolarinwa, Bukola V and Hembrecht, Sandra and Culhane, Rose Joyce and Narsiman, Abhi and Canavan, Clodagh T and Sørensen, Jan and Downey, Eithne and Allen, Michael and Butt, Abeeda and Power, Colm and McArdle, Orla and Morris, Patrick G and Healy, Nuala and McKenna, Laura and Hill, Arnold D K},
title = {Do Not Rush to Omit Sentinel Lymph Node Biopsy for Early Breast Cancer Patients},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2025.11.006}
}
EUVIMED